Resistance to subcutaneous and intramuscular insulin associated with deficiency of insulin-like growth factor (IGF) 2.
A diabetic patient is described whose serum was deficient in IGF 2. The patient responded appropriately to intravenous insulin but was resistant to subcutaneous and intramuscular insulin. His serum degraded insulin in vitro. This degradation was inhibited by IGF 2 and to a lesser extent by IGF 1 and insulin. We propose that this patient inactivated insulin at the injection site because of an insulin protease in his tissues that would normally be inhibited by serum IGF 2.
D000328:Adult; D006801:Humans; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000097:blood / Q000172:deficiency*; D007333:Insulin Resistance; D008297:Male; D010455:Peptides / Q000097:blood / Q000172:deficiency*; D013002:Somatomedins / Q000097:blood / Q000172:deficiency*
D007328:Insulin; D010455:Peptides; D013002:Somatomedins